Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014309)
◆英語タイトル:Clementia Pharmaceuticals Inc (CMTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014309
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene is an investigational retinoic acid receptor gamma agonist, and an oral therapy used to prevent the abnormal growth of bone in people with FOP. Clementia undertakes clinical trial for palovarotene in fibrodysplasia ossificans progressiva. The company operates through physician experts, researchers, and the rare disease community to study the treatment of FOP by tracking the natural course of the disease. It has presence in the US and Canada. Clementia is headquartered in Montreal, Quebec, Canada.

Clementia Pharmaceuticals Inc (CMTA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Clementia Pharma Secures USD60 Million Venture Financing 11
Clementia Pharma Raises USD60 Million in Venture Financing 13
Clementia Pharma Raises USD8.5 Million in Extended Series A Venture Financing 15
Clementia Pharma Raises US$20.8 Million In Series A Financing 16
Partnerships 17
Clementia Pharma Enters into Agreement with Instituto Ortopedico Rizzoli 17
Licensing Agreements 18
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 18
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 19
Clementia Pharma Enters into Licensing Agreement with Yamaguchi University 20
Clementia Pharma Enters into Licensing Agreement with Thomas Jefferson University 21
Clementia Pharma Enters into Licensing Agreement with F. Hoffmann-La Roche 22
Equity Offering 24
Clementia Pharma Completes Underwriters Exercise of Over-Allotment of Public Offering of Shares 24
Clementia Pharma Raises USD10 Million in Private Placement of Shares 26
Clementia Pharmaceuticals Inc – Key Competitors 27
Clementia Pharmaceuticals Inc – Key Employees 28
Clementia Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 13, 2017: Clementia Reports Third Quarter 2017 Financial Results and Business Highlights 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Clementia Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Clementia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Clementia Pharma Secures USD60 Million Venture Financing 11
Clementia Pharma Raises USD60 Million in Venture Financing 13
Clementia Pharma Raises USD8.5 Million in Extended Series A Venture Financing 15
Clementia Pharma Raises US$20.8 Million In Series A Financing 16
Clementia Pharma Enters into Agreement with Instituto Ortopedico Rizzoli 17
Clementia Pharma Enters into Licensing Agreement with Galderma R&D 18
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 19
Clementia Pharma Enters into Licensing Agreement with Yamaguchi University 20
Clementia Pharma Enters into Licensing Agreement with Thomas Jefferson University 21
Clementia Pharma Enters into Licensing Agreement with F. Hoffmann-La Roche 22
Clementia Pharma Completes Underwriters Exercise of Over-Allotment of Public Offering of Shares 24
Clementia Pharma Raises USD10 Million in Private Placement of Shares 26
Clementia Pharmaceuticals Inc, Key Competitors 27
Clementia Pharmaceuticals Inc, Key Employees 28
Clementia Pharmaceuticals Inc, Other Locations 29
Clementia Pharmaceuticals Inc, Subsidiaries 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析(Clementia Pharmaceuticals Inc (CMTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆